8
Views
1
CrossRef citations to date
0
Altmetric
Original Article

HIV-associated dementia and related disorders

&
Pages 237-243 | Published online: 11 Jul 2009

References

  • American Academy of Neurology AIDS Task Force. Nomenclature and research case definitions for neurologic manifestations of HIV-1 infection. Neurology 1986; 41: 778–785
  • Ayers M. R., Abrams D. I., Newell T. G., Friedrich F. Performance of individuals with AIDS on the Luria-Nebraska Neuropsychological Battery. International Journal of Clinical Neuropsychology 1991; 9: 101–105
  • Baldeweg T, Lovett E. Psychophysiology and neurophysiology of HIV infection. International Review of Psychiatry 1987; 3: 331–342
  • Baldeweg T., Gruzelier J. H., Catalan J., Pugh K., Lovett E., Riccio M., Hawkins D. Auditory and visual event-related potentials in a controlled investigation of gay men with HIV infection. Electroencephalography and Clinical Neurophysiology 1991; 88: 356–368
  • Baldeweg T., Gruzelier J. H., Stygall J., Lovett E., Pugh K., Liddiard D., Riccio M., Hawkins D., Catalan J. Detection of subclinical motor dysfunctions in early symptomatic HIV infection with topographical EEG. International Journal of Psychophysiology 1993a; 15: 227–238
  • Baldeweg T., Catalan J., Lovett E., Gruzelier J., Riccio M., Hawkins D. Long-term zidovudine reduces neurocognitive deficits in HIV-1 infection. AIDS 1993b; 9: 589–596
  • Baldeweg T., Riccio M., Gruzelier J., Hawkins D., Burgess A., Irving G., Stygall J., Catt S., Catalan J. Neurophysiological evaluation of zidovudine in asymptomatic HIV-1 infection: a longitudinal placebo-controlled study. Journal of the Neurological Sciences 1995a; 132: 162–169
  • Breitbart W., Marotta R., Platt M. M., Weisman H., Derevenco M., Grau C., Corbera K., Lund S., Jacobsen P. A double-blind trial of haloperidol, chlorpromazine and lorazepam in the treatment of delirium in hospitalized AIDS patients. American Journal of Psychiatry 1995b; 153: 231–237
  • Brouwers P., Moss H., Wolters P., Eddy J., Balis F., Poplack D. G. Effect of continuous infusion of zidovudine therapy on neuropsychologic functioning in children with symptomatic HIV. Journal of Paediatrics 1996; 117: 980–985
  • Brunetti A., Berg G., Di Chiro G., Cohen R. M., Yarchoan R., Pizzo P. Reversal of brain metabolic abnormalities following treatment of ADC with AZT: a PET-FDG study. Journal of Nuclear Medicine 1990; 30: 581–590
  • Budka H., Wiley C. A., Kleihues P., Artigas J., Ashbury A. K., Cho E. S. HIV-associated disease of the nervous system: review of nomenclature and proposal for neuropathology-based terminology. Brain Pathology 1989; 1: 143–152
  • Cantacuzino M. Till break of day. Heinemann, London 1991
  • Catalan J. HIV-associated dementia: review of some conceptual and terminological problems. International Review of Psychiatry 1993; 3: 321–329
  • Catalan J, Thornton S. Whatever happened to HIV-associated dementia?. International Journal of STD and AIDS 1991; 4: 1–4
  • Catalan J., Burgess A., Klimes I. The Psychological Medicine of HIV infection. Oxford Medical Publications, Oxford University Press, Oxford 1993
  • Catalan J., Meadows J., Baldeweg T. Epidemiology of HIV-associated dementia in London 1991–1994. London, Department of Health 1995
  • De Gans J., Portegies P. Neurological complications of infection with HIV-1. Clinical Neurology and Neurosurgery 1996; 91: 199–219
  • Elovaara I., Saar P., Valle S. L., Hokkanen L., Iivahainen M., Laholevirta L. EEG in early HIV-1 infection is characterized by anterior dysrhythmicity of low maximal amplitude. Clinical Electroencephalography 1989; 22: 515–521
  • Esterson A., Harris H., Kessinger J. The AIDS dementia unit. VIII International Conference on AIDS Amsterdam. 1991
  • Everall I. P. Neuropsychiatric aspects of HIV infection. Neurology, Neurosurgery and Psychiatry 1992; 58: 399–402
  • Fernandez F, Levy J. Psychiatric diagnosis and pharmacotherapy of patients with HIV infection. Review of Psychiatry 1995; 9: 614–630
  • Florence M. Noah's Ark-Red Cross Foundation: a Swedish model. AIDS Care 1990; 5: 467–470
  • Grant I., Atkinson J., Hesselink J., Kennedy C., Richman D., Spector S. Evidence for early central nervous system involvement in AIDS and other HIV infections. Annals of Internal Medicine 1994; 107: 828–836
  • Gray F., Belec L., Keohane C., De Truchis P., Clair B. Zidovudine therapy and HIV encephalitis: a ten-year neuropathological survey. AIDS 1987; 8: 489–493
  • Green J, Kocsis A. Counselling patients with AIDS-related encephalopathy. Journal of the Royal College of Physicians of London 1994; 22: 166–168
  • Harden C. L., Daras M., Tuchman A-J., Koppel B. S. Low amplitude EEGs in demented AIDS patients. Electroencephalography and Clinical Neurophysiology 1988; 87: 54–56
  • Hriso E., Kuhn T., Masdeu J., Grundman M. Extrapyramidal symptoms due to dopamine-blocking agents in patients with AIDS encephalopathy. American Journal of Psychiatry 1993; 148: 1558–1561
  • Janssen R. S., Nwanyanwu O. C., Selik R. M., Stehr-Green J. K. Epidemiology of HIV encephalopathy in the US. Neurology 1991; 42: 1472–1476
  • Kocsis A. Counselling those with AIDS dementia. Counselling in HIV infection and AIDS, J Green, A. McCreaner (Eds.). Blackwell Scientific Publications, Oxford 1990
  • Koralnik L. J., Beaumanoir A., Hausler R., Kohler A., Safran A. B., Delacroix R. A controlled study of early neurologic abnormalities in men with asymptomatic HIV infection. The New England Journal of Medicine 1989; 323: 864–870
  • Lyketsos C. G., Hanson A., Fishman M., Rosenblatt A., McHugh P., Treisman G. Manic Syndrome early and late in the course of HIV. American Journal of Psychiatry 1991; 150: 326–327
  • Maehlen J., Dunlop O., Dobloug J. H., Liestol K., Torvik A. Brain lesions in AIDS patients in Norway 1983–1992: unexplained changes with time and opposing effects of length of survival and AZT treatment. Clinical Neuropathology 1993; 12(suppl.)S12
  • Maj M., Janssen R., Satz P. The WHO cross cultural study on neuropsychiatric aspects of HIV-1 infection: preparation and pilot phase. British Journal of Psychiatry 1993; 159: 351–356
  • Maj M., Janssen R., Starace F., Zaudig M., Satz P., Sughondhabirom B. WHO Neuropsychiatric AIDS study—cross sectional phase. Archives of General Psychiatry 1991; 51: 39–49
  • Maj M., Satz P., Janssen R., Zaudig M., Starace F., D'Elia L. WHO Neuropsychiatric AIDS study—cross sectional phase: neuropsychological and neurological findings. Archives of General Psychiatry 1994a; 51: 51–61
  • Masdeu J., Yudd A., van Heertum R. L., Grundum M., Hriso E, O'Connell R. A. SPET in HIV encephalopathy: a preliminary report. Journal of Nuclear Medicine 1994b; 32: 1475–1477
  • Mayeux R., Stern Y., Tang M., Todak G., Marder K., Sano M. Mortality risk in gay men with HIV infection and cognitive impairment. Neurology 1991; 43: 176–182
  • McArthur J. C. Neurologic manifestations of AIDS. Medicine 1993; 66: 407–437
  • McArthur J. C., Miller E. N., Selnes O., Becker J. T., Cohen B. A., Starkey D. Effects of long-term AZT use on neuropsychological performance in the MACS. International Conference on the Neuroscience of HIV Infection Monterey. 1987
  • McArthur J. C., Hoover D. R., Bacellar H., Miller E. N., Cohen B. A., Becker J. T. Dementia in AIDS patients: incidence and risk factors. Neurology 1990; 43: 2245–2252
  • Meadows J, Catalan J. The needs of carers of patients with chronic brain disorder in HIV disease in the Thames Regions, London. Abstracts of AIDS' Impact, II International Conference Brighton, UK. 1993
  • Meadows J., Catalan J., Singh A., Burgess A. P. Prevalence of HIV-associated dementia in a central London Health District in 1991. IXth International Conference on AIDS Berlin. 1994
  • Meadows J., De Villiers B., Catalan J. Referrals to Patrick House, a residential home in central London, UK, for patients with HIV-related brain impairment. Abstracts of AIDS' Impact, II International Conference Brighton, UK. 1993
  • Navia B. A., Jordan B. D., Price R. W. The AIDS dementia complex: I clinical features. Annals of Neurology 1994; 19: 517–524
  • Navia B. A., Cho E., Petito C. K., Price R. W. The AIDS dementia complex: II neuropathology. Annals of Neurology 1986a; 19: 525–535
  • Newman S. P., Lunn S., Harrison M. Do asymptomatic HIV-seropositive individuals show cognitive deficit?. AIDS 1986b; 9: 1211–1220
  • Ollo C., Johnson R., Grafman J. Signs of cognitive change in HIV disease: an event-related potential study. Neurology 1995; 41: 109–215
  • Ostrow D., Grant I., Atkinson J. H. Assessment and management of the AIDS patient with neuropsychiatric disturbance. Journal of Clinical Psychiatry 1991; 49: 14–22
  • Ostrow D., Harris H., Mill K. Assessing a new model of inpatient subacute care for HIV-related dementia. VIIIth International Conference on AIDS Amsterdam. 1988
  • Parisi A., Strosselli M., DiPerri G. EEE in the early diagnosis of HIV-related subacute encephalitis: analysis of 185 patients. Clinical Electroencephalography 1992; 20: 1–5
  • Perdices M, Cooper D. A. Neuropsychological investigation of patients with AIDS and ARC. Journal of AIDS 1988; 3: 555–564
  • Pizzo P. A., Eddy J., Falloon J., Balis F. M., Murphy R. F., Moss H. Effect of continuous intravenous infusion of zidovudine in children with symptomatic HIV infection. New England Journal of Medicine 1991; 319: 889–896
  • Portegies P., De Gans J., Lange J. M., Derix M., Speelman H., Bakker M. Declining incidence of ADC after introduction of AZT treatment. British Medical Journal 1988; 299: 819–821
  • Price R. W., Brew B. J. AIDS commentary: the AIDS dementia complex. Journal of Infectious Diseases 1989; 158: 1079–1083
  • Riccio M., Burgess A., Hawkins D., Wilson B., Thompson C. Neuropsychological and psychiatric changes following treatment of ARC patients with zidovudine. International Journal of STD and AIDS 1988; 1: 435–437
  • Schmitt F. A., Bigley J. W., McKinnis R., Logue P. E., Evans R. W., Drucker J. L. Neuropsychological outcome of zidovudine treatment of patients with AIDS and ARC. New England Journal of Medicine 1990; 319: 1573–1578
  • Scurlock H., Singh A., Catalan J. Use of remoxipride in the treatment of manic syndromes in HIV-1 infection. Abstracts of IInd AIDS' Impact International Conference Brighton, UK. 1988
  • Selnes O. A., McArthur J. C., McArthur J. H., Saah A. Incidence of HIV dementia in the MACS: patterns of cognitive decline. International Conference on the Neuroscience of HIV infection Padua. 1994
  • Sidtis J. J., Gatsonis C., Price R. W., Singer E. J., Collier A. C., Richman D. D. Zidovudine treatment of the AIDS dementia complex: placebo-controlled trial. Annals of Neurology 1991; 33: 343–349
  • Sims R, Moss V. Terminal care for people with AIDS. Edward Arnold, London 1993
  • Singh A, Catalan J. Risperidone in HIV-related manic psychosis. The Lancet 1991; 344: 1029–1030
  • Snider W. D., Simpson D. M., Nielson S., Gold J. W. M., Metroka C. E., Posner J. B. Neurological complications of AIDS: analysis of 50 patient. Annals of Neurology 1994; 14: 403–418
  • Stern Y., Marder K., Bell K., Chen J., Doonief G., Goldstein S. Multidisciplinary baseline assessment of homosexual men with and without HIV infection: III Neurologic and neuropsychological findings. Archives of General Psychiatry 1983; 48: 131–138
  • Tross S., Price R. W., Navia B. A., Thaler H., Gold J., Hirsch D., Sidtis J. J. Neuropsychological characterization of the AIDS dementia complex: a preliminary report. AIDS 1991; 2: 81–88
  • World Health Organization. Report of the Second Consultation on the Neuropsychiatric aspects of HIV-1 infection. Geneva. 1988
  • Yarchoan R., Berg G., Brouwers P., Fischl M., Spitzer A. R., Wichman A. Response of HIV-associated neurological disease to zidovudine. The Lancet 1990; i: 132–135

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.